Skip to main content

and
  1. Article

    Open Access

    Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial

    Identifying patients with metastatic colorectal cancer who will have an early disease progression during induction chemotherapy (IC) and identifying patients who may have a chemotherapy-free interval (CFI) aft...

    Thomas Aparicio, Jaafar Bennouna, Karine Le Malicot in British Journal of Cancer (2020)